260
Participants
Start Date
December 16, 2020
Primary Completion Date
February 29, 2024
Study Completion Date
February 29, 2024
Enzastaurin Hydrochloride
mg
Placebo
mg
Temozolomide
mg/m\^2
Radiotherapy
Gy
New York University Medical Oncology Associates, New York
Icahn School of Medicine at Mount Sinai, New York
New York - Presbyterian - Weill Cornell Medical Center, New York
University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
Wake Forest Baptist Health - Comprehensive Cancer Center, Winston-Salem
Messino Cancer Centers, Asheville
Winship Cancer Institute of Emory University, Atlanta
Sylvester Comprehensive Cancer Center, Miami
Miami Cancer Institute, Miami
Lynn Cancer Institute, Boca Raton
Moffitt Cancer Center, Tampa
University of Alabama at Birmingham, Birmingham
Vanderbilt - Ingram Cancer Center, Nashville
Norton Cancer Institute - Multidisciplinary Clinic, Louisville
University of Kentucky Markey Cancer Center, Lexington
The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
University of Michigan Rogel Cancer Center, Ann Arbor
Henry Ford Health System, Detroit
John Nasseff Neuroscience Institute, Minneapolis
Mayo Clinic - Rochester, Rochester
Rush University Medical Center, Chicago
Washington University School of Medicine Center for Advanced Medicine, St Louis
Baylor University Medical Center, Dallas
Lynn Cancer Institute, Houston
University of Texas Health Science Center at Houston (UT Health), Houston
Mays Cancer Center, San Antonio
Austin Cancer Center - Park St. David's, Austin
University of Colorado Hospital Anschutz Cancer Pavilion, Aurora
Blue Sky Neurology, Englewood
University of Utah, Salt Lake City
Barrow Neurological Institute, Phoenix
Mayo Clinic - Arizona, Scottsdale
Cedars-Sinai Medical Center, Los Angeles
City of Hope Comprehensive Cancer Center - Duarte, Duarte
The University of Southern California, Pasadena
University of California San Diego Moores Cancer Center, La Jolla
University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange
University of California San Francisco Helen Diller Family Comprehensive CA Ctr, San Francisco
Beijing Tian Tan Hospital, Capital Medical University, Beijing
Sanbo Brain Hospital, Capital Medical University, Beijing
Peking Union Medical College Hospital, Beijing
Shengjing Hospital - Nanhu Campus, Shenyang
Huashan Hospital Affiliated to Fudan University, Shanghai
First Affiliated Hospital of USTC - Anhui Provincial Hospital, Hefei
General Hospital of Tianjin Medical University, Tianjin
Tianjin Huanhu Hospital, Xianshuigu
Tongji Hospital, Wuhan
Sun Yat-Sen University Cancer Center, Guangzhou
Shenzhen Second People's Hospital, Shenzhen
Tangdu Hospital, Xi'an
Smilow Cancer Hospital - New Haven, New Haven
Mayo Clinic - Jacksonville, Jacksonville
Masonic Cancer Center, Minneapolis
Hackensack Meridian Health - JFK Medical Center, Edison
The University of North Carolina at Chapel Hill, Chapel Hill
Penn State Health Milton S. Hershey Medical Center, Hershey
SCRI - Tennessee Oncology - Nashville - Centennial, Nashville
Seattle Cancer Care Alliance, Seattle
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency - Abbotsford, Abbotsford
British Columbia Cancer Agency - Victoria, Victoria
The Ottawa Hospital - General Campus, Ottawa
Hôpital Fleurimont, Sherbrooke
Saskatoon Cancer Center, Saskatoon
Lead Sponsor
Denovo Biopharma LLC
INDUSTRY